Shares of breakfast restaurant chain First Watch Restaurant Group (NASDAQ:FWRG)
jumped 7.7% in the morning session after TD Cowen upgraded the stock's rating from Hold to Buy and assigned a price target of $22, which implied a potential 20% upside. The firm anticipated improvements in same-store sales due to "more effective" marketing. This upgrade suggested that TD Cowen felt there was a decent possibility of an upward surprise to FWRG's growth projection, which could translate to improved investor sentiment.
Shares of fashion conglomerate PVH (NYSE:PVH)
jumped 18.7% in the morning session after the company reported impressive fourth quarter 2024 results, with sales and earnings exceeding Wall Street's expectations. In North America, sales remained steady, supported by the benefit of earlier wholesale shipments. Meanwhile, European sales declined as planned, reflecting the company's deliberate strategy to prioritize quality over volume.
Shares of multinational healthcare company Johnson & Johnson (NYSE:JNJ)
fell 5.6% in the morning session after a judge in Texas rejected the company's third attempt to use bankruptcy as a legal shield against lawsuits alleging its talcum powder products caused ovarian cancer.
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Cloudastructure reported full-year revenue of $1.4 million, up 125% on a year-over-year basis. The company reported a net loss of $6.5 million, or 45 cents per share, improved from a net loss of $9 million in 2023.
PVH shares are trading higher on Tuesday after the company reported fourth-quarter earnings on Monday after the market closed, which included beats on both revenue and EPS.
Applied DNA Sciences shares are trading higher by 18.7% during Tuesday's session. The company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety.
SoftBank considers $16.5B loan for US AI ambitions, may help lead $40B funding round in OpenAI, valuing it at $300B. Japan's AI project also continues.
